Acesion Pharma is a Danish biotech company founded in 2011. We are aiming to develop more efficacious and safer drugs for the treatment of atrial fibrillation (AF), the most common type of cardiac arrhythmia.
The scientific foundation of Acesion Pharma is the novel concept of treating AF by inhibiting the so-called SK channels. These are ion channels present in the heart where they are relevant for regulating the cardiac rhythm. Blocking this ion channel with a selective drug molecule constitutes a novel and promising target for developing improved treatment of AF.
Company Details
- Employees
- 19
- Founded
- -
- Address
- Ole Maaløes Vej 3, Copenhagen,capital Region 2200,denmark
- Phone
- 45 44 64 08 76
- co****@****rma.com
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- acesionpharma.com
- HQ
- Copenhagen, Capital Region
Acesion Pharma Questions
Acesion Pharma's helpline number is 45 44 64 08 76
Acesion Pharma's website is acesionpharma.com
Acesion Pharma's LinkedIn profile is https://dk.linkedin.com/company/acesion-pharma
Acesion Pharma has
19 employees.
View email and phone details for 19
employees at Acesion Pharma.
Acesion Pharma's industry is
Pharmaceutical Manufacturing
Acesion Pharma's top competitors are
Immudex,
Minervax Aps,
Adcendo,
Genmab,
Io Biotech,
Zerion Pharma,
Hoba Therapeutics,
Muna Therapeutics,
Hemab Therapeutics,
Macure Pharma.
Acesion Pharma's support email address is contact@acesionpharma.com
Acesion Pharma's categories are Pharmaceutical Manufacturing
Acesion Pharma's founding year is 2011
